Forty-eight-week evaluation of lopinavir/ritonavir, a new protease inhibitor, in human immunodeficiency virus-infected children

Xavier Sáez-Llorens^*, Avyi Violari, Carl O. Deetz, Richard A. Rode, Perry Gomez, Edward Handelsman, Stephen Pelton, Octavio Ramilo, Pedro Cahn, Ellen Chadwick, Upton Allen, Stephen Arpadi, Maria Mercedes Castrejón, Renee S. Heuser, Dale J. Kempf, Richard J. Bertz, Ann F. Hsu, Barry Bernstein, Cheryl L. Renz, Eugene Sun